SUBSCRIBE
SUBSCRIBE
News   Deals

Dohmen Acquires BioSoteria, Inc., the Market Leader in Drug Safety and Education

April 3, 2012 | 
1 min read
MILWAUKEE--(BUSINESS WIRE)--CEO Cynthia (Dohmen) LaConte announced today that the Dohmen Company has acquired BioSoteria, a leading provider of drug safety and risk management services to the biopharmaceutical industry.
Mergers & acquisitions
MORE ON THIS TOPIC
The path to precision. The road to the center of the target. The concept of goal achievement, precision, strategic direction, and focus on results. Polygonal design, blue background.
Deals
Lilly, AI biotech Profluent ink $2.25B pact in search of genetic medicine ‘holy grail’
April 28, 2026
 · 
2 min read
 · 
Gabrielle Masson
Abstract Weather Concept - Sun In Serene Sky With Flare Effect
Deals
Sun Pharma beams up Organon in $11.75B acquisition
April 27, 2026
 · 
1 min read
 · 
Gabrielle Masson
Big fish with dollar sign eating many small ones. Competition, merger, business, monopoly concept. EPS 8 vector illustration, no transparency
Deals
Lilly lands third oncology deal in 3 weeks, inking up to $2.3B for Ajax
April 27, 2026
 · 
2 min read
 · 
Gabrielle Masson
Illustration of two arrows merging into one
Deals
Amneal inks $1.1B Kashiv buyout to pursue biosimilar market leadership
April 23, 2026
 · 
2 min read
 · 
Nick Paul Taylor